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ABSTRACT
￿
The crude extract of venom glands of the polychaete annelid Glycera convoluta
triggers a large Cat+-dependent acetylcholine release from both frog motor nerve terminals
and Torpedo electric organ synaptosomes. This extract was partially purified by Concanavalin
A affinity chromatography. The biological activity was correlated in both preparations to a
300,000-dalton band, as shown by gel electrophoresis. This confirmed previous determinations
obtained with chromatographic methods. This glycoprotein binds to presynaptic but not
postsynaptic plasma membranes isolated from Torpedo electric organ. Pretreatment of intact
synaptosomes by pronase abolished both the binding and the venom-induced acetylcholine
release without impairing the high K+-induced acetylcholine release. Pretreatment of nerve
terminal membranes by Concanavalin A similarly prevented the binding and the biological
response. Binding to Torpedo membranes was still observed in the presence of EGTA. An
antiserum directed to venom glycoproteins inhibited the neurotoxin so we could directly
follow its binding to the presynaptic membrane. Glycera convoluta neurotoxin has to bind to
a ectocellularly oriented protein of the presynaptic terminal to induce transmitter release.
A neurotoxin from the venom glands of the polychaete an-
nelid Glycera convoluta enhances several hundred times the
frequency of miniature end-plate potentials (mepps)' at frog
neuromuscularjunctions and at Torpedonerve-electroplaque
junctions (15). This effect is Ca'-dependent and is observed
even in the presence of high concentration of tetrodotoxin
(15, 16). The active substance has been recently shown to be
a high molecular weight (300,000 daltons) protein that was
clearly separated from the low protease and phospholipase
activities of the crude venom (24). This substance has also
been found to induce acetylcholine (ACh) release from iso-
lated cholinergic Torpedo synaptosomes (9, 12). The release
starts after a short delay and lasts until exhaustion of the free
(cytoplasmic) ACh pool (9). The Glycera convoluta venom
(GCV)does not induce depletion of synaptic vesicles or other
intraterminal organelles (15). Changes in the distribution of
intramembrane particles were found in the freeze-fractured
plasma membrane of synaptosomes during GCV-induced
ACh release (12). These modifications seem related to the
ACh release process itself since they were also observed when
ACh release was triggered by KCI, gramicidin, or Ca" iono-
phore A 23187 (10).
'Abbreviations used in this paper:
￿
ACh, acetylcholine; GCV, Gly-
cera convoluta venom; mepps, miniature end-plate potentials.
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In view of the potential usefulness of GCV in studying the
mechanism of ACh release, it was important to know whether
the active molecule acted after binding specifically to the
presynaptic membrane. We chose to study the binding of
GCV to preparations of Torpedo synaptosomes. This seemed
most convenient because the Torpedo synaptosome prepara-
tion is a homogeneous population of pure cholinergic nerve
terminals that retain the properties of nerve terminals in situ
including the ability to release ACh. This release can be
continuously quantitated by a chemiluminescence method (8,
9). In addition, it is possible to prepare fractions of presynaptic
plasma membranes (20) allowing binding studies and evalu-
ation of biological activity on the same preparation. Direct
measurements of the neurotoxin binding could not, however,
be done since, up to now, this molecule is not available in
pure and active form. We therefore demonstrated the binding
by immunological methods. For quantitative studies, the
binding was indirectly evaluated by measuring the decrease
of the soluble activity after incubation of GCV with mem-
branes. These measurements were conducted in parallel at
frog neuromuscular junction and on Torpedo synaptosomes.
We report that the neurotoxin binds to an ectocellularly
oriented protein of the presynaptic plasma membrane. In
addition, the neurotoxinwas found to be a glycoprotein. This
permitted a 100-fold purification of this molecule in a one-
step affinity chromatography.
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Preparation of Venom Extract
Glvcera convoluta (Keferstein) were collected on the seashore near the
Marine Biological Station of Roscoff (France). The venom gland complexes
were immediately dissected and kept frozen at -80°C. After thawing, they were
homogenized at 0°C in 10 mM Na phosphate buffer (pH 7.2-7.4), leading to
final concentrations of 10-50 glands per ml (gl/ml). The homogenate was
centrifuged at 10,000 g for 10 min. The supernatant was recentrifuged at
160,000 g for 10 min (Beckman airfuge, Beckman Instruments, Inc., Rich-
mond, CA). The latter supernatant constituted the crude GCV.
Partial Purification of Venom Extract
GCV was fractionated by affinity chromatography on Con A-Sepharose 4B
(Pharmacia, Inc., Piscataway, NJ). GCV (200-400 glands in -10 ml) was
layered on top of a column containing Con A-Sepharose beads (8 ml settled
volume) washed with at least 80 ml of frog Ringer's solution. After washing
with 100 ml ofthe same solution, the biological activity was eluted by 0.25 M
a-methyl-o-mannoside and 0.25 M 1-0-methyl a-D-glucopyranoside (Sigma
Chemical Co., St. Louis, MO) dissolved in the Ringer's solution.
When the biological activity had to be estimated on synaptosomal suspen-
sions, an additional filtration through a G 75 Sephadex column was performed
either with GCV or with each of the fractions eluted from the affinity column
(9). The biological activity was recovered in the excluded volume of the G 75
Sephadex column. Protein was determined either by amidoschwarz staining
(23) or by a technique ofprotein-dye binding described by Bradford (3).
Estimation of Biological Activity
Frog Neuromuscular Junction:
￿
Mepps were recorded intracellularly using
conventional electrophysiological methods from single fibers of the cutaneous
pectoris muscle which was bathed in a Ringer's solution containing 110 mM
NaCl, 2.1 mM KCI, 1 .8 mM CaC12, 4 mM Hepes buffer adjusted to pH 7.2.
The Ringer's solution flowed continuously through a 2-ml Perspex chamberat
5.5 ml/min. Crude GCV or fractions thereof were dissolved in 15 or 20 ml of
Ringer's solution. They were perfused at the same rate, the first milliliters being
eliminated and the last I I ml being recirculated. After 8 min, the venom
solution was washed out with Ringer's solution. Mepp frequency was continu-
ously monitored by a system that detected the rising phase ofthe mepps. The
fiber potential was fed into an active band pass filter with a center frequency
of500 Hz. The filtered output signal wasthen fedto a Schmitttriggerconnected
to a microcomputer that permitted on-line storage ofeach inter-mepp interval
on a disket. Further processing was off-line.
Torpedo Synaptosomes: Torpedo synaptosomes were isolated from Torpedo
electric organ as previously described (11, 19). Aliquots of the synaptosomal
band (usually 30 ul deriving from 15 mg ofelectric organ) were resuspended in
250 ul of an alkaline Torpedo physiological medium (280 mM NaCl, 3 mM
KCI, 3.4 mM CaCIZ, 1 .8 mM MgCl2, 400 mM sucrose, 5.5 mM glucose, 50
mM Tris buffer adjusted to pH 8.6) to which acetylcholinesterase (EC 3.1.1 .7),
choline oxidase (EC 1.1.3.17), peroxidase (EC 1 .11.1 .7), and luminol were
added. ACh release was then continuously measured using the chemilumines-
cence method reported by Israël and Lesbats (8, 9).
Preparation of Antisera
The fractions eluted from the Con A column and corresponding to the peak
of the biological activity were concentrated by dialysis under negative pressure
(p Micro-Prodicon, Bio-Molecular Dynamics, Beaverton, OR; 15,000-mol-wt
cut-off). The concentrated fractions were emulsified in Freund's complete
adjuvant and injected intradermally in rabbit's foot sole at a dose of -200 gg
protein/rabbit. Three intradermal booster injections, each consisting of200 ug
of protein in Freund's incomplete adjuvant, were made at 1-mo intervals.
Rabbits were bled 10 d afterthe last injection.
Adsorption of Venom Fractions on Presynaptic
Plasma Membranes
Presynaptic plasma membranes were prepared by subfractionating Torpedo
synaptosomes, as described (20). Several membrane fractions (M3, M4, M5)
were obtained. The fractions M3 and M4 contained the presynaptic plasma
membrane; M5 was mainly composedofplasma membranes ofthe postsynaptic
cells. In some experiments, a crude fraction ofpresynaptic plasma membranes
was obtained directly from Torpedo electric organ homogenate, as described
(18). The membranes were kept frozen at -80°C. After thawing, they were
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washed in frog Ringer's solution and pelleted (160,000 g for 10 min) in a
Beckman airfuge (Beckman Instruments, Inc.). They were resuspended in
Ringer's solution and incubated for I to 2 h at room temperature in the
presence of aliquots of the venom fractions. After airfuge centrifugation
(160,000 g for 10 min), the biological activity recovered in the supernatantwas
immediately assayed. The membrane pellets were kept frozen at -80°C for
further electrophoresic studies.
Gel Electrophoresis
Gel electrophoresis was performed in a slab gel apparatus as described by
Laemmli (14). 40-u1 aliquots of the fractions eluted from the Con A column
were half-diluted with a dissociation buffer (final concentration 2.5% SDS, 5%
ß-mercaptoethanol, 10% glycerol, 5 mM Tris, pH 6.8) and incubated in boiling
water for 3-5 min. Running gels were either 5-15% gradient acrylamide gels
or 5 and 7.5% acrylamide gels. A 3% acrylamide stacking gel was used.
Electrophoresis was carried out for 5 h at a constant current of 40 mA. Gels
were fixed overnight in 50% methanol and silver stained according to Wray et
al. (26). Forprotein blotting, protein bandswere transferredafterelectrophoresis
from the gels to nitrocellulose filters (HAWP 304 FO, Millipore Co., Bedford,
MA) according to Bowen et al. (2). Diffusion was allowed to occur at 4°C for
40 h in a buffer solution (in millimolars: NaCl, 100; EDTA, 2; Tris, 20; pH
7.6). The filters were incubated with rabbit antisera directed to venom fractions
(see above). The Ig binding was visualized using peroxidase-labeled antibodies
to rabbit IgG (Institut Pasteur, Paris) as previously described (I8).
RESULTS
Quantitation of GCV Biological Activity
We have systematically evaluated the biological activity of
GCV by assessing the GCV-induced ACh release at the frog
neuromuscularjunction and from Torpedo synàptosomes. At
the frog neuromuscular junction, GCV increased the mepp
frequency (14). As shown in Fig. 1, the effect is dose-depend-
ent and easily reversed by washing. It is therefore possible to
use this preparation to assay the activity of venom fractions
using the same fiber throughoutthe experiment. In the range
10-160 venom glands/liter, the increase in mepp frequency
induced by GCV is directly proportional to the concentration
(Fig. 1, inset). In the experiments reported below, the mepp
frequency was simultaneously recorded from two different
muscle fibers and the venomdoses were adjusted to bring the
final concentration to 50-80 glands/liter.
On Torpedo synaptosomes, the venomtriggers ACh release
which can be continuously monitored by a chemilumines-
cence method. In the absence of precursor recycling, the
transmitter release is maintained until complete exhaustion
of the free ACh compartment (9). To eliminate interferences
ofGCV with the chemiluminescent reaction, it was necessary
to pass GCV through a G 75 Sephadex column. The time
course of ACh release triggered by different GCV doses is
shown in Fig. 2 . After a short delay, the rate of ACh release
is directly proportional to the venom concentration whereas
the total amount ofACh released is dose-independent (Fig. 2,
inset). In the experiments reported below, the venom doses
were adjusted to give a final concentration of -0.5 glands/
MI.
Partial Purification on Con A-Sepharose Column
GCV was fractionated by affinity chromatography on Con
A-Sepharose 413. The biological activity was recovered in the
fraction eluted in one step by a mixture of 0.25 M a-methyl-
D-mannoside and 0.25 M 1-O-methyl a-D-glucopyranoside in
Ringer's solution (Fig. 3). The elution profiles were very
reproducible throughout the experiments. The biological ac-200
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FIGURE 1
￿
Dose-dependence of GCV effect and assay of venom fractions at the frog neuromuscular junction. Mepps are
intracellularly recorded from the same muscle fiber and their mean frequency is evaluated during successive 15-s intervals. At
the beginning of the experiment, a test dose of GCV is applied for 8 min (bar), then washed out. The fractions to be tested are
then applied under the same conditions during the interval denoted by-//-. At the end of the experiment (150 min later in this
case), increasing doses of GCV are perfused for 8 min (bars) and washed out. For each dose, the final GCV concentration is
indicated in venom gland/liter. The mean mepp frequency F is evaluated during periods of 9 min starting 2 min after venom
introduction to take into account the initial and washing delays. The resting mepp frequency F0 is subtracted and F-Fo is plotted
against the GCV concentration (inset). The activity of the venom fractions is determined from the regression line.
FIGURE 2
￿
Dose-dependence of GCV effect on synaptosomal ACh
release. Time-course of ACh release triggered by increasing doses
of GCV. The slope of the rising phase (" in inset) increases with the
venom concentration . The total amount of ACh released (p in
inset), estimated from the surface of the light response, is inde-
pendent of the venom dose and corresponds to the free ACh pool
(9). For low venom doses, the long duration of the response leads
to underestimation of the total amount released. 20 gI of synapto-
somes deriving from 10 mg of electric organ were used for each
determination in 0.28 ml of reaction medium . The light responses
were calibrated by comparison with known ACh standards injected
in each tube.
tivity estimated using Torpedo synaptosomes paralleled that
measured at frog neuromuscular junctions. The mean total
recovery of biological activity was good (72% for synapto-
somes and 85% for frog neuromuscularjunction). Since only
2% ofthe GCV proteins were recovered in the eluted fractions,
such an affinity column permits an important increase in the
specific activity of the neurotoxin. The highest purification
was obtained in fraction 5 (x 165 when determined with
synaptosomes and x 245 when determined at frog neuro-
muscular junctions). In all experiments, the recovery of bio-
logical activity was higher when estimated at the frog neuro-
muscular junction.
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Loss of Biological Activity Following Incubation
with Presynaptic Plasma Membranes
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FIGURE 3 Chromatography of GCV on Con A-Sepharose. The
protein content (0) and biological activity on Torpedo synaptosomes
(A) and frog neuromuscular junctions (/) are expressed as percents
of the same parameters for the sample layered on top ofthe column.
Five experiments were pooled. The mean protein content of the
initial sample was 213 ± 36,ug/gl (mean ± SEM).
In seven experiments, where GCV was incubated with
presynaptic plasma membranes prepared from either Torpedo
electric organ or synaptosomes, the biological activity was no
longer detectable either on synaptosomes or at frog neuro-
muscular junctions. To determine whether this effect was
specific for the presynaptic membranes, GCV (2.7 glands)
was incubated for 2 h at room temperature with different
Torpedo electric organ membrane fractions (20) in 180 1r.l of
frog Ringer's solution. After centrifugation, the biological
activity of the supernatant was assayed. The results obtained
using different concentrations ofeach membrane fraction are
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1739shown in Fig. 4. In a previous work (20), it was shown that
after fractionation of Torpedosynaptosomes, the presynaptic
plasma membranes are recovered in fractions M3 and M4
whereas fraction M5 contains essentially plasma membrane
fragments ofthe postsynaptic cell. Fraction M5, even at high
concentrations, failed to remove the biological activity. By
contrast, fractions M3 and M4 could completely suppress this
activity for membrane protein concentration of the order of
50 Ag protein per venom gland. It is worth noting that, though
incubation was carried out with Torpedo membranes, mea-
surements basedon either frog mepp frequency or ACh release
from Torpedo synaptosomes led to identical results for both
the relative potency of the membrane fractions and the con-
centrations inhibiting 50% of the biological activity.
Control experiments were carried out to rule out a possible
degradation of the neurotoxin during incubation with mem-
branes. The residual activity was studied as a function ofthe
duration of incubation with crude presynaptic plasma mem-
branes (18). GCV and membrane concentrations were ad-
justed so as to obtain a large but not total loss ofactivity. Fig.
5 shows that the loss of activity occurred rapidly and then
stabilized: for incubations longer than 2 min, no further
decrease was observed.
Membrane-Venom Interactions in
Ca2'-free Media
Removal of the GCV neurotoxin by presynaptic plasma
membranes was not abolished when Ca
2+ concentration was
strongly reduced. Presynaptic membranes directly prepared
from Torpedoelectric organ homogenates were incubated for
1 h with GCV (90 ug protein/gland) in the presence of 2.5
mM EGTA (free Ca: 20 uM). A total inhibition of the
biological activity on both frog neuromuscular junction and
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FIGURE 4
￿
Inhibition of venom activity following incubation with
Torpedo membranes. After filtration through G 75 Sephadex, GCV
was incubated for 2 h with fractions containing presynaptic plasma
membranes M3 (0) and M4 (O) or membranes of the postsynaptic
cell M5 (0). After centrifugation, the biological activity of the
supernatant (residual activity, expressed as percent of filtrated GCV
activity), was measured at the frog neuromuscular junction (A) and
on Torpedo synaptosomes (8). It is plotted against the membrane
protein concentration expressed in micrograms of membrane pro-
tein per venom gland on a logarithmic scale. Results from two
experiments.
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Torpedosynaptosomes was then observed as in control incu-
bations carried out in the presence of 1 .8 mM Ca". It has
been checked that no loss ofactivity occurred when GCV was
incubated with 2.5 mM EGTA alone.
In view of the fact that GCV-induced ACh release was
found to be Ca2'-dependent on in situ nerve terminals (15,
16), this problem was reinvestigated on isolated Torpedo
synaptosomes (Fig. 6). The synaptosomes were prepared in
Ca2'-free media, and GCV was passed through a G.50 Seph-
adex column equilibrated with 10 mM phosphate buffer at
pH 7.4. Various amounts of Ca
2+ were added in the reaction
mixture just before GCV introduction. In these conditions, a
clear Ca2'-dependence was observed. MgZ+ was not able to
substitute for CaZ+.
Absence of Membrane-Venom Interactions in
Synaptosomes Pretreated with Pronase
To determine the kind of interaction between the neuro-
toxin and the presynaptic plasma membrane, it was ofinterest
to see if an ectocellularly oriented membrane protein was
involved. We knew that pronase induces the loss of ^-30% of
membrane proteins without impairing the depolarization in-
duced ACh release (Morel et al., in preparation). This enzyme
was thus used to treat synaptosomes which were first tested
for theirability to release ACh upon venom application, then
subfractionated so that their plasma membranes might be
tested for their ability to remove the biological activity from
the crude extract.
Intact synaptosomes were incubated for 2 h at room tem-
perature either with or without 0.25 mg/ml pronase (Boehrin-
ger Mannheim Biochemicals, Indianapolis, IN). ACh release
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FIGURE 5 Time course of
inhibition of GCV activity
by presynaptic mem-
branes. The residual activ-
ity after variable durations
of incubation with crude
presynaptic plasma mem-
branes (100 Ilg protein/
gland) was measured on
Torpedo synaptosomes.
Activity is expressed as
percent of that of GCV in-
cubated in the absence of
membranes.
FIGURE 6
￿
Ca2+ dependence of GCV-induced ACh release from
Torpedo synaptosomes. 30 liI of synaptosomes (corresponding to
15 mg of electric organ) prepared in Ca"-free media were exposed
to GCV (0.3 glands/ml) in the presence of 6.5 mM MgZ+ (O) or of
various Ca2+ concentrations (9). The rate of ACh release was
estimated from the slope of the light emission rising phase and
calibrated by internal ACh standards.induced by 100 mM KCl or GCV was then tested (Fig. 7).
While the KCl-induced release was only slightly decreased
after pronase treatment, the venom-induced release was abol-
ished.
Control and pronase-treated synaptosomes were then di-
luted and centrifuged (10,000 g for 20 min), a procedure that
allows elimination of pronase. They were disrupted (osmotic
shock associated with freezing and thawing) and their mem-
branes recovered in parallel as described (20). The membranes
were incubated for 1 h at room temperature with GCV (55
Ag protein/gland). As expected, GCV incubated with control
membranes was no longer active either at the frog neuromus-
cular junction or on Torpedo synaptosomes. By contrast, the
activity was completelyrecovered afterincubation with mem-
branes of pronase-treated synaptosomes (respectively 94 and
96% recovery for the two test preparations). The above results
show that pronase destroys a membrane protein interacting
with the neurotoxinwithout affecting the ACh release process
itself.
Absence of Membrane Venom Interactions in
Preparations Treated by Con A
After application of a test dose of GCV and washing with
Ringer's solution, a frog muscle was exposed for 50 min to
500 Itg/ml Con A dissolved in Ringer's solution. After a 15-
min wash-out of the unbound Con A, the same test dose of
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FIGURE 7
￿
ACh release from control and pronase-treated synapto-
somes . ACh release from 30 yI of synaptosomes (corresponding to
17 mg of electric organ) was triggered by addition of either KCI
(100 mM final concentration) or Sephadex filtered GCV (0.2 gl/ml
final concentration). Synaptosomes had been incubated for 2 h at
room temperature without (CONTROL) or with (PRONASE) 0.25
mg/ml pronase. The ACh release was quantified by comparison
with ACh standards injected in the same test tube. Note that
pronase present in the synaptosomal samples reduces the sensitivity
of the chemiluminescent reaction.
GCV was completely inactive. Similarly, Torpedo synapto-
somes were treated for 90 min at 4°C by 500 Ag/ml Con A.
Unbound Con A was removed by dilution and centrifugation
of the synaptosomes which were then tested for their ability
to release ACh. Whereas ACh release triggered by 60 mM
KCl was not affected, the venom-induced release was reduced
to 30-50% of the control. When the dimeric derivative suc-
cinyl-Con A was used in place of the tetrameric lectin at 500
Ag/ml, neither KCl-induced nor venom-induced ACh release
was reduced. No attempt was made to quantify the inhibitory
effect of Con A since the synaptosomal suspension contains
sugars (5 mM glucose and 400 mM sucrose) which interact
with the lectins.
Crude presynaptic plasma membranes (250 pg of protein
in 180 ul of Ringer's solution) were incubated at 4°C for 50
min with various concentrations of Con A or succinyl-Con
A. The lectins were washed out by three successive centrifu-
gations and resuspensions (Beckman airfuge, Beckman Instru-
ments, Inc. 160,000 g for 5 min). The membranes were then
incubated with GCV (92 pg protein/venom gland) for 1 h at
room temperature. After centrifugation, the biological activity
of the supernatant was tested on synaptosomes and frog
muscle (Fig. 8). Whereas control membranes (incubated with-
out lectin) totally removed the activity, Con A-treated mem-
branes were much less efficient. Membranes treated with 500
,ug/ml Con A retained only 10% of the activity. The dimeric
form of the lectin was about 10 times less potent in preventing
the binding of the neurotoxin.
Inhibition of the Venom Activity by Antiserum
Rabbits were immunized against the partially purified neu-
rotoxin obtained by Con A affinity chromatography (fractions
5, 6, and 7 of Fig. 3). Because of interferences of rabbit sera
with the chemiluminescent reaction, the effects ofthe antisera
were tested only on frog neuromuscular preparations. GCV
passed through G 75 Sephadex (11 glands/ml finalconcentra-
tion) was incubated with antiserum at various dilutions in
Ringer's solution at 4°C for 3 h. After centrifugation (160,000
g for 15 min in Beckman airfuge, Beckman Instruments,
Inc.), the biological activity was assayed in the supernatant.
The results are shown in Fig. 9. A complete inhibition was
obtained for antiserum concentration of the order of 1 ~1
FIGURE 8
￿
GCV biological activity after incubation with presynaptic
membranes pretreated by Con A or Suc. ConA. Isolated presynaptic
plasma membranes were incubated with various concentrations of
ConA (O, 9) or Suc. ConA (p, 0), and unbound lectin was washed
out (see Results). They were then incubated with GCV. After
centrifugation, the biological activity recovered in the supernatant
was measured on Torpedo synaptosomes (", ") and at the frog
neuromuscular junction (p, p), and compared with GCV activity.
Percent recovery is plotted against the lectin concentration used
for the isolated membranes pretreatment.
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FIGURE 9
￿
Inhibition of venom activity by a rabbit antiserum raised
against GCV glycoproteins . After incubation with different antise-
rum concentrations, the biological activity was measured at the frog
neuromuscular junction .
antiserum per venom gland . This demonstrated the immu-
noreactivity of the neurotoxin . The antisera have been used
to characterize the venom glycoproteins .
Correlation between Protein Patterns and the
Biological Activity ofGCV Fractions
GCV was partially purified on Con A-Sepharose column .
The biological activity of the eluted fractions was measured
on Torpedo synaptosomes and at frog neuromuscular junc-
tions . An aliquot ofthe fraction exhibiting the highest specific
activity (4 in Fig . 10) was incubated with crude presynaptic
plasma membranes for 20 min at room temperature (^-150
ug of protein for a biological activity equivalent to that of one
venom gland). After centrifugation, no activity was recovered
in the supernatant (fraction 4') . Equal aliquots ofthe different
fractions were boiled for 4 min in the presence of 2.5% SDS
and 5% 0-mercaptoethanol, then submitted to gel electropho-
resis . Numerous bands were observed after silver staining.
One ofthem (-300,000 mol wt) seemed to correlate with the
biological activity in the fractions . In particular, it was no
longer detectable in fraction 4' which had been incubated in
the presence of presynaptic plasma membranes . It must be
emphasized that, even in the purest fraction, this protein
represents only a few percent of the fraction glycoproteins .
Since antisera directed to GCV glycoproteins were able to
inhibit the neurotoxin activity (Fig . 9), it was necessary to
check that they recognized the 300,000-mol-wt protein . Frac-
tions 4 and 4' were concentrated by dialysis under negative
pressure and boiled as described above . Protein bands were
separated on a 7.5% acrylamide gel and transferred by diffu-
sion on nitrocellulose filters. After incubation with rabbit
antisera directed toGCV glycoproteins (diluted to 1 :500), the
Ig binding was visualized using peroxidase-labeled antibodies
to rabbit IgG (Fig . 11, left). As expected, numerous bands
were recognized by the antisera . The 300,000-mol-wt band
was labeled in fraction 4 whereas it was not detected in
fraction 4' . No other obvious differences were observed be-
tween these two fractions, a finding that agrees with previous
determination ofthe neurotoxin molecular weight using other
methods (24) .
The presynaptic membranes that had been used to adsorb
the neurotoxin of fraction 4 and control presynaptic mem-
branes were solubilized in parallel in 5% cholate in 10 mM
Tris buffer pH 8 . The protein concentration was - 1 .5 mg/
ml . The glycoproteins were purified on Con A-Sepharose as
described for the venom, except for the presence of 1% cholate
in all solutions . The eluted proteins were concentrated by
dialysis against 10 mM Tris buffer pH 8 under negative
pressure . They were boiled for 4 min in 2.5% SDS-5 0-
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mercaptoethanol and then submitted to gel electrophoresis in
a 5% acrylamide gel. The proteins were transferred, incubated
with antiserum directed to venom glycoproteins, and labeled
as described above . No binding of the antiserum to control
presynaptic membranes was detected (Fig . 11, right) . This
made it possible to detect the venom glycoproteins bound to
the incubated presynaptic membranes . A band (mol wt,
180,000) was heavily labeled . Other bands were much less
labeled . Since they are heavily labeled in the venom fractions
FIGURE 10 Protein patterns of the purified venom fractions .
Venom glycoproteins were purified on Con A-Sepharose, boiled in
2.5% SIDS 5% ß-mercaptoethanol for 5 min and electrophoresed in
a 5-15% acrylamide gradient gel (40 mA, 5 h) . Proteins were silver
stained . The biological activity recovered in each fraction is indi-
cated in percent of GCV activity. Each slot contains a fraction
aliquot deriving from six venom glands . Fraction 4' corresponds to
fraction 4 after incubation with presynaptic plasma membranes and
removal of membrane-bound proteins by centrifugation . Protein
standards (Pharmacia) were used for the determination of molecular
weights .
FIGURE 11
￿
Immunological labeling of GCV glycoproteins. Left : la-
beling of glycoproteins of fraction 4 (active) and 4' (4 inactivated
by incubation with presynaptic membranes) . Each fraction derived
from 88 venom glands. Right : labeling of glycoproteins recovered
from presynaptic plasma membranes incubated (MBP) or not (PPM)
with fraction 4 prepared from 118 venom glands . See Results for
experimental procedure .and since the membrane pellet was not washed, they most
likely represent venom components unspecifically trapped in
the membrane pellet.
DISCUSSION
In the present work, we confirm that the venom biological
activity is correlated with the presence of a 300,000-mol-wt
protein band. This band was observed aftergel electrophoresis
of samples boiled for 5 min in the presence of 2.5% SDS and
5% ß-mercaptoethanol, suggesting that this protein is made
up of a single polypeptide chain. The neurotoxin could be
partially purified on a Con A affinity column and is therefore
a glycoprotein. The close similarity between results obtained
using either frog neuromuscularjunctions or Torpedo synap-
tosomes, especially adsorption of the activity on isolated
Torpedo presynaptic plasma membranes, strongly suggests
that the same molecule is responsible for the venom-induced
ACh release in both preparations. The neurotoxin represents
only a small fraction of the venom gland proteins. From Fig.
10, the neurotoxin represents at most 5% of the proteins of
the most enriched fraction (fraction 4) which was enriched
^-200-fold when compared with GCV (213 )Ag protein/gland,
see Fig. 3). An upper limit of the neurotoxin content of a
venom gland can thus be estimated to 0.05 x 213/200 = 0.05
tig protein (300,000 mol wt) corresponding to 5 .10-8 x 6.1023/
3.105 = 1011 molecules/gland. Since the effect of a solution
containing 10 glands/liter is easily detectable (Fig. 1), the
neurotoxin is active in the picomolar range.
The large size ofthe GCV neurotoxin, the short delay, and
reversibility of the effect at neuromuscular junctions argued
against the penetration of the toxin into the nerve terminal
and suggested a direct action on the presynaptic plasma
membrane. Binding of the neurotoxin to membranes pre-
pared from Torpedo electric organ synaptosomes was directly
demonstrated by immunological labeling: the antiserum that
was shown not to react with any protein of the presynaptic
membrane, but reacted with many GCV glycoproteins, heav-
ily labeled a single band (180,000 mol wt) associated with
incubated membranes (Fig. 11). Since the 300,000-mol-wt
band corresponding to the neurotoxin is labeled by the anti-
serum and is the only band of fraction 4 (Figs. 10 and 11) to
disappear after incubation with presynaptic membranes, the
180,000-mol-wt band bound to presynaptic membranes nec-
essarily derives from the neurotoxin. The difference in molec-
ular weight could be explained by a modification of the
neurotoxin once bound or by its proteolysis during the steps
(solubilization, purification on Con A column, and concen-
tration) which precede the gel electrophoresis.
However, such an approach did not allow a quantitative
evaluation of the binding that was indirectly obtained by
measuring the residual activity of the supernatant of GCV
incubated with presynaptic plasma membranes. The loss of
biological activity during incubation (Fig. 5) rapidly stabilized
at a constant level. This ruled out the possibility of an inac-
tivation of the neurotoxin by a membrane-bound protease
since a complete inactivation following an exponential decay
would then be observed. The binding appeared to be specific
for the presynaptic plasma membrane since incubation with
otherplasma membrane fractions from the electric organ only
slightly affected the GCV activity (Fig. 4). Externally applied
pronase suppressed the binding, thus demonstrating that the
neurotoxin bound to an ectocellularly oriented protein. Pre-
treatment of the membranes by Con A inhibited the binding
ofthe neurotoxin, succinyl-Con A being 10 times less potent.
The difference in potency between the dimeric and tetrameric
form of the lectin suggests that blockade ofthe binding results
from a reduced accessibility due to cross-linkage ofglycopro-
teins (5). Such an aggregation is likely to be passive since it
was obtained on isolated membranes. Nerve terminals pre-
treated by pronase or Con A still released transmitter follow-
ing depolarization. By contrast, GCV-induced ACh release
was abolished. This strongly suggested that the binding ofthe
neurotoxin was necessary for inducing the biological effect.
The stability ofthe binding with Torpedopresynaptic mem-
branes is in apparent contrast to the rapid washing of the
effect at frog neuromuscular junctions. However, it must be
remembered that the GCV-induced discharge is different at
frog neuromuscular junctions and at Torpedo nerve-electro-
plaque junctions (15, 24). At the former, the effect results
from the summation of mepp bursts whereas at the latter, the
miniature potential discharge is more continuous. It is thus
possible that, at frog nerve terminals, the neurotoxin unbinds
after having exerted its effect.
The GCV-induced ACh release from nerve terminals in
situ has been shown to be Ca-dependent (15, 16). In the
present work, GCV action on isolated Torpedo nerve termi-
nals was also found to be Ca2'-dependent, a feature that could
not be detected in earlier experiments carried out with less
reliable and less sensitive methods (12, 21). Since the neuro-
toxin binding does not require Cat+, GCV very likely acts by
triggering a Ca2' entry into the nerve terminal. The prereq-
uisite of a binding cannot completely rule out a channel-
forming action for GCV. Such an action has been reported to
occur in artificial lipid bilayers exposed to gland extract of
the related species Glycera dibranchiata (13). However, G.
dibranchiata extracts were not able to trigger ACh release
when applied to our preparations (unpublished results). Al-
ternatively, the protein that binds GCV could be involved in
the control of Ca
21 membrane permeability.
Among the neurotoxins that act presynaptically (see refer-
ence 6 for a review), a-latrotoxin purified from black widow
spider venom (4) resembles GCV in its ability to trigger
quantal transmitter release (7). Its effect occurs also after
binding to the presynaptic plasma membrane (17, 25). The
binding site is a protein not found in non-neuronal tissues
(17, 25). Prior treatment with Con A abolishes both the
binding (17, 25) and the toxin-induced release (1, 17, 22).
The binding of a-latrotoxin or GCV neurotoxin to a protein
found only in presynaptic plasma membrane raises the ques-
tion of the function of these proteins. At the present time, no
data are available that would permit deciding whether or not
they are directly involved in the release process itself.
Received for publication 29 March 1983, and in revised form 16
August 1983.
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